Composite drug membranes of gelatin/chitosan for therapy of glaucoma by trabeculectomy were prepared through solvent volatilization, using triamcinolone acetonide as a model drug. The membranes were characterized by FT- IR, X-RD and SEM. Their degradability and swelling ability and biocompatibility were studied. The results showed that biocompatibility , flexibility, swelling ability and degradability of the composite films were better than pure film of chitosan . The composite membrane containing 25% (w/w) of gelatin was best. The drug was loaded in film in crystallite. The rabbit eyes experiment after 8 weeks showed that the form of follicle was all right, and ophthalmototus maintain in the perfect level.
参考文献
| [1] | Kwunchit Oungbho;Bern W Mulle.Chitosan Sponges as Sustained Release Drug Pharm[J].International Journal of Pharmaceutics,1997(156):229-237. |
| [2] | Mima S;Miya M;Iwamoto R;Yoshikawa S.Highly Deacetylated Chitosan and Its Properties[J].Journal of Applied Polymer Science,1983(28):1909-1917. |
| [3] | Sabnis S.;Block LH. .Chitosan as an enabling excipient for drug delivery systems - I. Molecular modifications[J].International Journal of Biological Macromolecules: Structure, Function and Interactions,2000(3):181-186. |
| [4] | Santavirta S .Immu Response to Polyglycolic Acid Implant[J].Journal of Bone and Joint Surgery-British Volume,1990,72(B):597-598. |
上一张
下一张
上一张
下一张
计量
- 下载量()
- 访问量()
文章评分
- 您的评分：
-
10%
-
20%
-
30%
-
40%
-
50%